This inventor holds 4 USPTO granted patents. Top assignees: Ariad Gene Therapeutics, Inc., Ariad Pharmaceuticals, Inc.. Active years: 2000-2002.
Company Filing History:
Years Active: 2000-2002
Title: Sridaran Natesan: Innovator in Genetic Engineering
Introduction
Sridaran Natesan is a prominent inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of genetic engineering, holding a total of 4 patents. His work focuses on the regulation of transcription and the development of novel fusion proteins.
Latest Patents
Natesan's latest patents include innovative compositions and methods for the regulation of transcription. This invention relates to novel fusion proteins that activate transcription, along with nucleic acid constructs encoding these proteins. These advancements are crucial for the genetic engineering of cells. Another notable patent involves heterologous transcription factors, providing novel materials and methods for the heterologous expression of transcription factors. This invention is useful for effecting transcription of target genes in genetically engineered cells or organisms.
Career Highlights
Throughout his career, Natesan has worked with notable companies such as Ariad Gene Therapeutics, Inc. and Ariad Pharmaceuticals, Inc. His expertise in genetic engineering has positioned him as a key player in the development of innovative therapeutic solutions.
Collaborations
One of his notable collaborators is Michael Z Gilman, with whom he has worked on various projects in the field of genetic engineering.
Conclusion
Sridaran Natesan's contributions to genetic engineering through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in the field.